Regenerative Medical Technology Group Inc.
Regenerative Medical Technology Group Inc. operates in the regenerative medicine industry in the United States and internationally. It provides products, solutions, equipment, services, and training to doctors and their staff in the application of stem cell therapies. The company is also involved in the treatment of patients; provision of training and seminars; and resale of kits, products, equip… Read more
Regenerative Medical Technology Group Inc. (RMTG) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.007x
Based on the latest financial reports, Regenerative Medical Technology Group Inc. (RMTG) has a cash flow conversion efficiency ratio of 0.007x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-203.73K) by net assets ($-30.05 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Regenerative Medical Technology Group Inc. - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how Regenerative Medical Technology Group Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Regenerative Medical Technology Group Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Regenerative Medical Technology Group Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
X Bioscience Public Company Limited
BK:XBIO
|
-0.028x |
|
Noble Metal Group Incorporated
V:NMG-H
|
0.001x |
|
S-Oil Corp. Pfd. Series 1
KQ:010955
|
N/A |
|
Janus Electric Holdings Ltd
AU:JNS
|
0.000x |
|
SEBinvest - Europa Small Cap AKL
CO:SEIESCP
|
N/A |
|
IMPERIAL TOBACCO
MU:ITB
|
N/A |
|
CRYOLIFE
BE:CYL
|
0.038x |
|
ISHS MSCI GER
BE:ISVP
|
N/A |
Annual Cash Flow Conversion Efficiency for Regenerative Medical Technology Group Inc. (2014–2024)
The table below shows the annual cash flow conversion efficiency of Regenerative Medical Technology Group Inc. from 2014 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-27.36 Million | $850.70K | -0.031x | -261.68% |
| 2023-12-31 | $-21.80 Million | $-419.20K | 0.019x | -79.31% |
| 2022-12-31 | $-11.98 Million | $-1.11 Million | 0.093x | -93.64% |
| 2021-12-31 | $-6.76 Million | $-9.88 Million | 1.462x | +2803.44% |
| 2020-12-31 | $-6.41 Million | $-322.75K | 0.050x | -6.58% |
| 2018-12-31 | $-4.54 Million | $-244.64K | 0.054x | +2157.65% |
| 2017-12-31 | $-2.56 Million | $-6.12K | 0.002x | -96.55% |
| 2016-12-31 | $-5.51 Million | $-380.93K | 0.069x | +560.45% |
| 2015-12-31 | $-5.55 Million | $-58.14K | 0.010x | -37.97% |
| 2014-12-31 | $-9.29 Million | $-156.76K | 0.017x | -- |